Nutraceutical Excipients Market by Functionality (Binders, Fillers & Diluents, Coating Agents, and Flavoring Agents), End Product (Prebiotics, Probiotics, Proteins & Amino Acids, and Vitamins), Form (Dry and Liquid), and Region - Global Forecast to 2025
Market Segmentation
| Report Metrics | Details |
|
Market size available for years |
2020 - 2025 |
|
CAGR % |
7.3 |
Top 10 companies in Nutraceutical Excipients Market
[258 Pages Report]The global nutraceutical excipients market size is projected to reach USD 4.9 billion by 2025, at a CAGR of 7.3%. The global market is driven by advances in nanotechnology used to impart new functions to excipients and a wide range of applications in the food & beverage and dietary supplements industry. However, the decrease in the returns on R&D investments and high clinical trials and registration restraints the market growth prospects. The high use of excipients with multifunctional properties is witnessed as an emerging trend among the key players along with a rising number of government initiatives and awareness campaigns is expected to create new growth opportunities for the growth of the market.
Market dynamics – Drivers, restraints, opportunities, and challenges
Driver: Advancements in nanotechnology equipped with new features to drive the growth of the market
Nanotechnology-enabled drug delivery systems (NDDS) are used to cater to the issue of drug toxicity. There are two major approaches to use nanotechnology as a drug delivery system (DDS). The first is to reduce the size of nutraceutical drug crystals to ensure enhanced solubility and bioavailability, while the second approach is to use some form of nano-carrier for effective delivery of active ingredients. In March 2009, the scientific committee of the European Food Safety Agency published an opinion on nanoscience and nanotechnology regarding food and feed safety. A document offering guidance on how to assess potential risks associated with certain food-related uses of nanotechnology was followed in May 2011, providing practical recommendations to regulators on how to assess applications that use engineered nanomaterials in food additives, enzymes, flavorings, food contact materials, novel foods, food supplements, feed additives, and pesticides.
Poor drug physicochemical properties can be improved by associating the drug with a pharmaceutical carrier. A drug delivery system (DDS) can enhance a drug’s pharmacokinetics and cellular penetration. Moreover, the drug delivery system (DDS) may also address obstacles arising from low drug solubility, degradation, fast clearance rates, nonspecific toxicity, and inability to cross biological barriers. Hence, the use of nanotechnology for improving the functionalities of excipients is also projected to drive the growth of the nutraceutical excipients market during the forecast period.
Restraint: Decrease in returns on R&D investments and high costs of clinical trials and registration.
Excipients and nutraceutical products are clinically and chemically developed, and hence, require extensive R&D investments, clinical trials, and approvals from respective authorities in different countries/regions. In addition, developing such products is not a short-term activity, as it includes the formulation, trial & testing, and commercializing it into the market. However, high R&D investments do not give equal returns in terms of productivity, as even after successful molecule discovery, the cost of bringing a new nutraceutical product and a new excipient into the market is significantly high. In addition, other players in the market develop alternate and cheaper solutions, amidst the trial and testing procedures of one product or solution by another company, which leads to wastage of time, money, and efforts required to come to the later stages of that product, thereby disrupting the complete process of new product development. At the same time, the risk of failure also remains high. The cost of proving the effectiveness of an excipient through clinical trials is also relatively expensive and can be a major hindrance to the development of novel excipients in the market.
Opportunity: High use of excipients with multifunctional properties is witnessed as an emerging trend among key players.
Multifunctional excipients are a class of excipients that include pre-processed and co-processed excipients that provide added functionalities to the formulation. For example, Silicified Micro-Crystalline Cellulose is a processed combination of MCC and colloidal silicon dioxide. These functionalities include flowability, compressibility, particle size distribution, shape, and porosity. The term multifunctional excipient is also extended to products that serve multiple roles in the formulation of dietary supplement and functional food & beverage line of products; for example, Ludipress is a co-processed product containing lactose, Kollidon, and Kollidon-CL, which serves the role of DC diluent with binder and disintegrant properties.
The demand for excipients with improved functionalities in the nutraceutical industry remains high, while also minimizing the drawbacks of incorporated excipients. According to the International Pharmaceutical Excipient Council (IPEC), a co-processed excipient is “a combination of two or more compendial or non-compendial excipients designed to physically modify their properties in a manner not achievable by simple physical mixing, and without significant chemical change.”
Excipient manufacturers are primarily focusing on developing newer excipients blends to achieve multi-functionalities, and, in turn, to grow strategically, since old excipients cannot address all the challenges related to nutraceutical formulations and the delivery of active ingredients. Thus, the multi-functionality of excipients helps in catering to the increased demand among industry players by saving on the costs incurred to produce a customized excipient.
Challenge: Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumer perception of dietary supplements as pharmaceutical drugs and their false claims.
The majority of the population is skeptical about the consumption of nutraceutical products, particularly the dietary supplement products. In addition, the increase in unawareness among rural and semi-urban consumers about dietary supplements and the lack of education regarding the same discourages key players from investing. This population contributes to a major share of the non-dietary supplement consuming population in the developing and non-developing countries. In addition, consumers perceive dietary supplements as medical drugs and are apprehensive about incorporating the same in their daily dietary lifestyles. Due to these factors, a number of manufacturers are focusing on developing different formulations of supplements, such as gummies, soft chews, and others, on mitigating the fear of consuming tablets and capsules as nutraceuticals. However, these formulations are still in the early stage of entering the global market. In contrast, tablets and capsules in the nutraceutical market already have a majority share, which hinders the growth of this market.
By form, the dry segment is estimated to account for the largest share in the market in 2020.
The dry form of nutraceutical excipients accounted for a larger market share, as compared to the liquid form. The popularity of the dry form can be attributed to its cost-effectiveness and convenience in multiple applications. An increase in demand for dry beverage mixes with additional nutrients, including customized mixes and consumer preference for fortified beverages are fueling the growth of the dry segment in the market.
The binders segment is estimated to account for the largest share in the nutraceutical excipients market in 2020, by functionality.
Based on functionality, binders accounted for the largest market share in 2019, followed by the fillers & diluents functionality segment. Binder is increasingly being used by dietary supplement manufacturers since these excipients are formulated to act as an adhesive to “bind together” powders, granules, and other dry ingredients to impart the required mechanical strength. Binders can also help in adding volume to low-active dose tablets, resulting in producing effective tablets with appropriate actives by holding the ingredients together. In addition, some binders also act as fillers and diluents in an array of application products, namely magnesium stearate, which is used widely as food and supplement additive. Due to factors such as versatility and vital importance in gaining product efficiency, binders are gaining traction and are witnessing a rise in consumption as an excipient in the nutraceutical industry.
The segment estimated to account for the largest share in the market in 2020, by end product, is the probiotics segments.
Probiotics are yeast and good bacteria that are beneficial for consumers, as they enhance digestion and gut health, improve immunity, increase nutrient absorption, and lower the chances of food allergies. Probiotic products are offered in different forms, including yogurt and drinks, and supplement forms such as tablets and capsules. However, there are two main challenges to develop a probiotic formulation viable for commercial utilization. The first one is the quality of health attributes that the probiotic organisms can confer, and the second one is the stability of the formulation until the end of its shelf life. Companies are focusing on developing and offering probiotic blend products, which includes APIs (Active Pharmaceutical Ingredient), containing probiotic formulations by using different types of excipients. Among the excipients used in these blends for probiotics formulation, mannitol was found the most suitable, which helped in the enhancement of the shelf life of end-products.
North America dominated the global nutraceutical excipients market in 2019; however, Asia Pacific market is projected to grow at the highest CAGR during the forecast period.
North America accounted for the largest market share in 2019. The market in North America is dominating, owing to the concentration of the global players such as DuPont (US), Kerry (Ireland), Cargill (US), and Ingredion (US). The market for nutraceutical excipients here is mature, and hence, the growth is moderate compared to other regions. Other factors contributing to the growth of nutraceutical excipients in North American region include the busy lifestyle of consumers, prevalence of chronic diseases due to hectic lifestyles, and an increase in awareness among consumers regarding the health benefits of nutritional foods, including food supplements, which has driven the demand for functional food products. In addition, the use of technological advancements and new product launches have made excipients available for a wide range of applications in the fortified food & beverage, dietary supplements, and nutraceuticals sectors, which is projected to drive the growth of the market in the region.
The Asia Pacific region is projected to be the fastest-growing market for nutraceutical excipients from 2020 to 2025. The rise in income and purchasing power, rapid growth of the middle-class population, increase in consumer awareness about health & fitness, and rise in consumer demand for nutritional & healthy products provide promising prospects for growth and diversification in the region’s food sectors, such as nutraceuticals. The region is attracting investors for setting up production facilities due to the liberalization of foreign direct investments in the food sector, the ease of availability of raw materials, skilled labor, land, and equipment at a lower cost. Also, the market for nutraceutical excipients in the region is relatively not as mature as the market in the North American region, which further propels the growth prospects for the Asia Pacific region.
Key Market Players
This report includes a study of marketing and development strategies, along with the product portfolios of the leading companies in the market. The key players in the market include The nutraceutical excipients market also consists of key start-up players, which include IMCD (Netherlands), Hilmar Ingredients (US), Innophos Holdings Inc (US), JRS Pharma (Germany), Biogrund GmbH (Germany), Pharma Line Int'l Corp (South Korea), Jigs Chemical (India), Panchamrut Chemicals (India), Azelis Chemical Ltd (Europe), and Daicel Group (Japan).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size estimation |
2018-2025 |
|
Base year considered |
2019 |
|
Forecast period considered |
2020–2025 |
|
kUnits considered |
Value (USD) and Volume (KT) |
|
Segments covered |
|
|
Regions covered |
|
|
Companies studied |
|
Target Audience:
- Supply-side: Nutraceutical excipients manufacturers, raw material suppliers, importers, and exporters
- Demand-side: Dietary supplement product manufacturers, fortified foods and beverages product manufacturers, retailers, distributors, and wholesalers.
- Regulatory side: Concerned government authorities, commercial research & development (R&D) institutions, and other regulatory bodies
- Associations and industry bodies: Food and Agriculture Organization (FAO), United States Department of Agriculture (USDA), Environmental Protection Agency (EPA), the Food Safety Council (FSC), European Food Safety Authority (EFSA), Arthritis Foundation, World Health Organization (WHO), All India Food Processing Association (AIFPA), National Center for Biotechnology Information (NCBI), National Library of Medicine (NLM), National Institutes of Health (NIH), Center for Food Safety (CFS), World Bank, and Organization for Economic Co-operation and Development (OECD).
By Functionality:
-
Binders
- Cellulose
- Povidone
- Starch
- Other binder types
- Fillers and diluents
- Disintegrants
- Coating agents
- Flavoring agents
- Lubricants
- Other functionalities
By Form:
- Dry
- Liquid
By End product:
- Protein & amino acids
- Omega-3 fatty acids
- Vitamins
- Minerals
- Prebiotics
- Probiotics
- Other end products
By Region:
- North America
- Europe
- Asia Pacific
- South America
- The Middle East and Africa
Recent Developments
- In June 2020, IMCD announces the extension of its partnership with DuPont Health and nutrition (US). This development will benefit both the companies in strengthening their footprints in Kenya, Uganda, and Egypt by offering a combined line of products to distinct industry users.
- In March 2020, Azelis Chemical Ltd signed an agreement with CosBond (China), a specialty chemical and food ingredient distributor, to acquire it. This development helped Azelis strengthen its distribution network in the Chinese market with the expertise of CosBond’s existing network channel and reach.
- In December 2019, DuPont signed an agreement to merge its Nutrition & Biosciences business with IFF (US). The development details include valuing the combined company at USD 45.4 Billion. DuPont owned a majority of the shares, which is 55.4% and the remaining 44.6% by IFF, which is unanimously approved. This development is expected to help the company broaden its capabilities offering nutritional ingredients and solutions to global consumers.
Frequently Asked Questions (FAQ):
What is the current size of the global nutraceutical excipients market?
The global nutraceutical excipients market was valued at USD 3.4 billion in 2020 and is projected to reach USD 4.9 billion by 2025, at a CAGR of 7.3%.
What mandates exists in some regions for the production, distribution, and consumption of nutraceutical excipients?
For instance, in Canada Health Canada provides specifications for all excipients, including the ones that are not included in the final product (solvents and nitrogen). According to Health Canada, if an excipient is Schedule B compendial monograph, it means that the excipient is tested as per the requirements of the standard, eliminating the need for any documentation. If the claim for the excipient is non-Schedule B compendial monograph, such as House standard, or includes tests that are supplementary to the ones appearing in Schedule B compendial monograph, a copy of the specification should be provided for the excipient
Which are the key star players in the global nutraceutical excipients market?
DuPont (US), BASF SE (Germany), Roquette Freres (France), Ingredion INC (US), and Cargill Inc (US), are the major star players in the nutraceutical excipients market.
What are the upcoming growth opportunities that nutraceutical excipient manufacturers are focusing on in the future?
Excipient manufacturers are primarily focusing on developing newer excipients blends to achieve multiple functionalities, and, in turn, to grow strategically, since old excipients cannot address all the challenges related to nutraceutical formulations and the delivery of active ingredients.
What are the key growth strategies adopted by major market players in the nutraceutical excipient market?
The leading companies adopted various strategies such as new service launches, acquisitions, expansions & investments, and mergers. To sustain in the competitive market, the key players adopted partnerships and agreements as the major strategies in the nutraceutical excipients market. Mergers & acquisitions accounted for nearly 47% of all strategic developments undertaken by the key players in the nutraceutical excipients market during the review period and witnessed increased adoption. The companies adopted this strategy to expand their product range and geographical presence in the developing markets. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 30)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
FIGURE 1 REGIONS COVERED
1.4 PERIODIZATION CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES, 2015-2019
1.6 UNITS CONSIDERED
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 35)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key Data from Secondary Sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of Primaries
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION
FIGURE 3 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS/HYPOTHESIS FOR THE STUDY
2.5 LIMITATIONS OF THE STUDY
2.6 MARKET SCENARIOS CONSIDERED DUE TO THE IMPACT OF COVID-19
2.6.1 SCENARIO-BASED MODELLING
2.7 COVID-19 HEALTH ASSESSMENT
FIGURE 4 COVID-19: THE GLOBAL PROPAGATION
FIGURE 5 COVID-19 PROPAGATION: SELECT COUNTRIES
2.8 COVID-19 ECONOMIC ASSESSMENT
FIGURE 6 REVISED GDP FORECASTS FOR SELECT G20 COUNTRIES IN 2020
2.8.1 COVID-19 IMPACT ON THE ECONOMY-SCENARIO ASSESSMENT
FIGURE 7 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 8 SCENARIOS IN TERMS OF RECOVERY OF THE GLOBAL ECONOMY
3 EXECUTIVE SUMMARY (Page No. - 48)
FIGURE 9 NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2020 VS. 2025 (USD MILLION)
FIGURE 10 MARKET SIZE, BY FUNCTIONALITY, 2020 VS. 2025 (USD MILLION)
FIGURE 11 MARKET SIZE, BY END PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 12 MARKET SHARE & GROWTH (VALUE), BY REGION
FIGURE 13 IMPACT OF COVID-19 ON THE GLOBAL MARKET, BY SCENARIOS, 2020-2021
4 PREMIUM INSIGHTS (Page No. - 53)
4.1 ATTRACTIVE OPPORTUNITIES IN THE MARKET
FIGURE 14 NUTRACEUTICAL EXCIPIENTS: AN EMERGING MARKET WITH IMMENSE GROWTH POTENTIAL
4.2 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION
FIGURE 15 ASIA PACIFIC TO GROW AT THE HIGHEST RATE IN THE NUTRACEUTICAL EXCIPIENTS MARKET FROM 2020 TO 2025
4.3 MARKET FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY
FIGURE 16 THE BINDERS SEGMENT, BY FUNCTIONALITY, IS ESTIMATED TO DOMINATE THE MARKET IN 2020 (VALUE)
4.4 MARKET FOR NUTRACEUTICAL EXCIPIENTS, BY FORM
FIGURE 17 THE DRY SEGMENT IS PROJECTED TO DOMINATE THE MARKET FROM 2020 TO 2025 (USD MILLION)
4.5 MARKET FOR NUTRACEUTICAL EXCIPIENTS, BY END PRODUCT
FIGURE 18 THE PROBIOTICS SEGMENT IS PROJECTED TO DOMINATE THE MARKET FROM 2020 TO 2025 (USD MILLION)
4.6 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY AND COUNTRY
FIGURE 19 THE BINDERS SEGMENT, BY FUNCTIONALITY, ACCOUNTED FOR THE LARGEST SHARE IN THE NORTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET IN 2019
FIGURE 20 THE US, FOLLOWED BY JAPAN, OCCUPIED A MAJOR SHARE IN THE GLOBAL MARKET IN 2019
FIGURE 21 GLOBAL REALISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
FIGURE 22 GLOBAL OPTIMISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
FIGURE 23 GLOBAL PESSIMISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
5 MARKET OVERVIEW (Page No. - 58)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 NUTRACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increased focus on preventive care is encouraging investments in products/solutions, which, in turn, is driving the demand for nutraceutical excipients
FIGURE 25 NUMBER OF DEATHS CAUSED GLOBALLY, BY DISEASE, IN 2017 (MILLION)
FIGURE 26 POPULATION AGED 60 YEARS OR ABOVE, BY REGION
5.2.1.2 Advancements in nanotechnology equipped with new features to drive the growth of the market
5.2.1.3 Rise in demand for fortified food products due to the increase in health consciousness among consumers
FIGURE 27 PERCEIVED HEALTHFULNESS OF NUTRIENTS IN FOOD
5.2.1.4 Introduction of mandates on food fortification by government organizations
5.2.2 RESTRAINTS
5.2.2.1 Decrease in returns on R&D investments and high costs of clinical trials and registration
5.2.3 OPPORTUNITIES
5.2.3.1 High use of excipients with multifunctional properties is witnessed as an emerging trend among key players
5.2.4 CHALLENGES
5.2.4.1 Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumer perception on dietary supplements as pharmaceutical drugs and their false claims
5.3 ECOSYSTEM/ MARKET MAP
FIGURE 28 FOOD & BEVERAGE ADDITIVES: ECOSYSTEM VIEW
FIGURE 29 FOOD & BEVERAGE ADDITIVES: MARKET MAP
FIGURE 30 NUTRACEUTICALS AND DIETARY SUPPLEMENTS: ECOSYSTEM VIEW
FIGURE 31 NUTRACEUTICALS AND DIETARY SUPPLEMENTS: MARKET MAP
5.4 YC & YCC SHIFT
FIGURE 32 YC & YCC SHIFT FOR THE NUTRACEUTICAL EXCIPIENTS MARKET
5.5 VALUE CHAIN ANALYSIS
FIGURE 33 NUTRACEUTICAL EXCIPIENTS - VALUE CHAIN
6 PATENT ANALYSIS (Page No. - 68)
FIGURE 34 GEOGRAPHICAL ANALYSIS: PATENT APPROVAL FOR THE NUTRACEUTICAL EXCIPIENTS MARKET, 2015-2020
TABLE 2 LIST OF IMPORTANT PATENTS FOR NUTRACEUTICAL EXCIPIENTS, 2019-2020?
7 ORGANIZATIONS/ REGULATIONS GOVERNING THE NUTRACEUTICAL EXCIPIENTS AND NUTRACEUTICAL PRODUCTS MARKET (Page No. - 71)
7.1 INTRODUCTION
TABLE 3 DEFINITIONS AND REGULATIONS FOR NUTRACEUTICALS AROUND THE WORLD
7.2 NORTH AMERICA
7.2.1 CANADA
7.2.2 US
7.2.3 MEXICO
7.3 EUROPEAN UNION (EU)
7.3.1 FRANCE
7.3.2 RUSSIA
7.3.3 SPAIN
7.4 ASIA PACIFIC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 AUSTRALIA & NEW ZEALAND
7.5 SOUTH AMERICA
7.5.1 BRAZIL
7.5.2 ARGENTINA
7.6 MIDDLE EAST & AFRICA
7.6.1 ISRAEL
8 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT (Page No. - 76)
8.1 INTRODUCTION
FIGURE 35 MARKET SHARE, BY END PRODUCT, 2020 VS 2025
TABLE 4 MARKET SIZE, BY END PRODUCT, 2018-2025 (USD MILLION)
TABLE 5 MARKET SIZE, BY END PRODUCT, 2018-2025 (KT)
TABLE 6 GLOBAL REALISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY END PRODUCT, 2020-2021 (USD MILLION)
TABLE 7 GLOBAL OPTIMISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY END PRODUCT, 2020-2021 (USD MILLION)
TABLE 8 GLOBAL PESSIMISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY END PRODUCT, 2020-2021 (USD MILLION)
8.2 PROBIOTICS
8.2.1 INCREASING INCLINATION OF CONSUMERS TOWARD IMMUNITY ENHANCING PRODUCTS POST-COVID-19 TO DRIVE THE MARKET GROWTH FOR PROBIOTICS IN THE COMING YEARS
TABLE 9 MARKET SIZE IN PROBIOTICS, BY REGION, 2018-2025 (USD MILLION)
TABLE 10 MARKET SIZE IN PROBIOTICS, BY REGION, 2018-2025 (KT)
8.3 PREBIOTICS
8.3.1 INCREASE IN DIGESTIVE ISSUES AMONG CONSUMERS RESULT IN ACIDITY AND INFLAMMATORY ISSUES, WHICH ENCOURAGES THE CONSUMPTION OF PREBIOTICS AS A PREVENTIVE MEASURE
TABLE 11 MARKET SIZE IN PREBIOTICS, BY REGION, 2018-2025 (USD MILLION)
TABLE 12 MARKET SIZE IN PREBIOTICS, BY REGION, 2018-2025 (KT)
8.4 PROTEINS & AMINO ACIDS
8.4.1 INCREASED POPULARITY OF PROTEINS AND AMINO ACIDS AMONG THE YOUTH POPULATION TO DRIVE THE GROWTH OF THE MARKET
TABLE 13 MARKET SIZE IN PROTEINS & AMINO ACIDS, BY REGION, 2018-2025 (USD MILLION)
TABLE 14 MARKET SIZE IN PROTEINS & AMINO ACIDS, BY REGION, 2018-2025 (KT)
8.5 VITAMINS
8.5.1 PREVALENCE OF VITAMIN DEFICIENCIES AMONG CONSUMERS LEAD TO INCREASED USE IN DAILY DIETS, WHICH, IN TURN, DRIVES THE MARKET GROWTH FOR NUTRACEUTICAL EXCIPIENTS
TABLE 15 MARKET SIZE IN VITAMINS, BY REGION, 2018-2025 (USD MILLION)
TABLE 16 MARKET SIZE IN VITAMINS, BY REGION, 2018-2025 (KT)
8.6 MINERALS
8.6.1 BENEFITS OFFERED FOR OPTIMAL FUNCTIONING OF BRAIN AND HEART IN THE HUMAN BODY TO DRIVE THE GROWTH OF THE MARKET
TABLE 17 MARKET SIZE IN MINERALS, BY REGION, 2018-2025 (USD MILLION)
TABLE 18 MARKET SIZE IN MINERALS, BY REGION, 2018-2025 (KT)
8.7 OMEGA-3 FATTY ACIDS
8.7.1 MULTIPLE BENEFITS OFFERED BY OMEGA-3 FATTY ACIDS TO HUMAN HEALTH IS ENCOURAGING ITS CONSUMPTION ACROSS REGIONS
TABLE 19 MARKET SIZE IN OMEGA-3 FATTY ACIDS, BY REGION, 2018-2025 (USD MILLION)
TABLE 20 NUTRACEUTICAL EXCIPIENTS MARKET SIZE IN OMEGA-3 FATTY ACIDS, BY REGION, 2018-2025 (KT)
8.8 OTHER END PRODUCTS
8.8.1 GROWING AWARENESS PERTAINING TO HEALTH-BENEFITTING DIETARY SUPPLEMENTS OFFERS ADDITIONAL NUTRIENTS, WHICH DRIVE THE GROWTH OF THE MARKET
TABLE 21 MARKET SIZE IN OTHER END PRODUCTS, BY REGION, 2018-2025 (USD MILLION)
TABLE 22 MARKET SIZE IN OTHER END PRODUCTS, BY REGION, 2018-2025 (KT)
9 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM (Page No. - 90)
9.1 INTRODUCTION
FIGURE 36 MARKET SHARE, BY FORM, 2020 VS 2025
TABLE 23 MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
TABLE 24 MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (KT)
TABLE 25 GLOBAL REALISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY FORM, 2020-2021 (USD MILLION)
TABLE 26 GLOBAL OPTIMISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY FORM, 2020-2021 (USD MILLION)
TABLE 27 GLOBAL PESSIMISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY FORM, 2020-2021 (USD MILLION)
9.2 DRY
9.2.1 MULTIFUNCTIONAL PROPERTIES OF DRY NUTRACEUTICAL EXCIPIENTS AND THEIR COST-EFFECTIVENESS TO DRIVE THE GROWTH OF THIS SEGMENT IN THE GLOBAL MARKET
TABLE 28 DRY NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
TABLE 29 MARKET SIZE, BY REGION, 2018-2025 (KT)
9.3 LIQUID
9.3.1 POTENTIAL GROWTH OPPORTUNITIES FOR LIQUID NUTRACEUTICAL EXCIPIENTS DUE TO INNOVATIONS IN ITS FORMULATIONS TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 30 LIQUID NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
TABLE 31 MARKET SIZE, BY REGION, 2018-2025 (KT)
10 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY (Page No. - 96)
10.1 INTRODUCTION
FIGURE 37 NUTRACEUTICAL EXCIPIENTS MARKET SHARE, BY FUNCTIONALITY, 2020 VS 2025
TABLE 32 MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 33 MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (KT)
TABLE 34 GLOBAL REALISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY FUNCTIONALITY, 2020-2021 (USD MILLION)
TABLE 35 GLOBAL OPTIMISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY FUNCTIONALITY, 2020-2021 (USD MILLION)
TABLE 36 GLOBAL PESSIMISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY FUNCTIONALITY, 2020-2021 (USD MILLION)
10.2 BINDERS
10.2.1 INCREASED ACCEPTABILITY AND USE OF BINDING AGENTS IN PRODUCTS TO DRIVE THE GROWTH OF THE GLOBAL MARKET
TABLE 37 MARKET SIZE FOR BINDERS, BY REGION, 2018-2025 (USD MILLION)
TABLE 38 MARKET SIZE FOR BINDERS, BY REGION, 2018-2025 (KT)
TABLE 39 MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 40 MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (KT)
10.2.2 CELLULOSE
TABLE 41 MARKET SIZE FOR CELLULOSE, BY REGION, 2018-2025 (USD MILLION)
TABLE 42 MARKET SIZE FOR CELLULOSE, BY REGION, 2018-2025 (KT)
10.2.3 POVIDONE
TABLE 43 MARKET SIZE FOR POVIDONE, BY REGION, 2018-2025 (USD MILLION)
TABLE 44 MARKET SIZE FOR POVIDONE, BY REGION, 2018-2025 (KT)
10.2.4 STARCH
TABLE 45 MARKET SIZE FOR STARCH, BY REGION, 2018-2025 (USD MILLION)
TABLE 46 MARKET SIZE FOR STARCH, BY REGION, 2018-2025 (KT)
10.2.5 OTHER BINDER TYPES
TABLE 47 MARKET SIZE FOR OTHER BINDER TYPES, BY REGION, 2018-2025 (USD MILLION)
TABLE 48 MARKET SIZE FOR OTHER BINDER TYPES, BY REGION, 2018-2025 (KT)
10.3 FILLERS & DILUENTS
10.3.1 USE OF ACTIVE INGREDIENTS IN A NUTRACEUTICAL PRODUCT ENCOURAGE THE USE OF FILLERS AND DILUENTS AS EXCIPIENTS IN THE GLOBAL MARKET
TABLE 49 MARKET SIZE FOR FILLERS & DILUENTS, BY REGION, 2018-2025 (USD MILLION)
TABLE 50 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR FILLERS & DILUENTS, BY REGION, 2018-2025 (KT)
10.4 DISINTEGRANTS
10.4.1 HIGH CONSUMPTION OF DIETARY SUPPLEMENTS IN THE FORM OF ORAL DOSAGES OR TABLETS TO DRIVE THE GROWTH OF THE DISINTEGRANTS SEGMENT
TABLE 51 MARKET SIZE FOR DISINTEGRANTS, BY REGION, 2018-2025 (USD MILLION)
TABLE 52 MARKET SIZE FOR DISINTEGRANTS, BY REGION, 2018-2025 (KT)
10.5 COATING AGENTS
10.5.1 INNOVATIONS IN COATING AGENTS OF EXCIPIENT PRODUCTS AND THEIR APPLICATIONS IN DIETARY SUPPLEMENT PRODUCTS TO DRIVE THE MARKET GROWTH
TABLE 53 MARKET SIZE FOR COATING AGENTS, BY REGION, 2018-2025 (USD MILLION)
TABLE 54 MARKET SIZE FOR COATING AGENTS, BY REGION, 2018-2025 (KT)
10.6 FLAVORING AGENTS
10.6.1 INCREASE IN NEED FOR MASKING STRONG AND UNAPPEALING FLAVORS TO DRIVE THE GROWTH OF THE FLAVORING AGENTS SEGMENT
TABLE 55 MARKET SIZE FOR FLAVORING AGENTS, BY REGION, 2018-2025 (USD MILLION)
TABLE 56 MARKET SIZE FOR FLAVORING AGENTS, BY REGION, 2018-2025 (KT)
10.7 LUBRICANTS
10.7.1 INCREASE IN NEED FOR REDUCING FRICTION AND KEEPING THE FORMULATION DURING THE PRODUCTION PROCESS INTACT DRIVES THE GROWTH OF THE LUBRICANTS SEGMENT
TABLE 57 MARKET SIZE FOR LUBRICANTS, BY REGION, 2018-2025 (USD MILLION)
TABLE 58 MARKET SIZE FOR LUBRICANTS, BY REGION, 2018-2025 (KT)
10.8 OTHER FUNCTIONALITIES
10.8.1 INCREASE IN HEALTH BENEFITS OF NUTRACEUTICAL EXCIPIENTS AND USE IN DIETARY SUPPLEMENTS TO DRIVE THE GROWTH OF THE OTHER FUNCTIONALITIES SEGMENT
TABLE 59 NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR OTHER FUNCTIONALITIES, BY REGION, 2018-2025 (USD MILLION)
TABLE 60 MARKET SIZE FOR OTHER FUNCTIONALITIES, BY REGION, 2018-2025 (KT)
11 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION (Page No. - 115)
11.1 INTRODUCTION
FIGURE 38 GEOGRAPHIC SNAPSHOT (2020-2025): RAPIDLY GROWING MARKETS ARE EMERGING AS NEW HOTSPOTS
TABLE 61 MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY REGION, 2018-2025 (USD MILLION)
TABLE 62 MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY REGION, 2018-2025 (KT)
TABLE 63 GLOBAL REALISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
TABLE 64 GLOBAL OPTIMISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
TABLE 65 GLOBAL PESSIMISTIC SCENARIO: COVID-19 IMPACT ON THE GLOBAL MARKET SIZE, BY REGION, 2020-2021 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 39 NORTH AMERICA: MARKET SNAPSHOT
TABLE 66 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 67 NORTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY COUNTRY, 2018-2025 (KT)
TABLE 68 NORTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018 -2025 (USD MILLION)
TABLE 69 NORTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (KT)
TABLE 70 NORTH AMERICA: MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 71 NORTH AMERICA: MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (KT)
TABLE 72 NORTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY END PRODUCT, 2018-2025 (USD MILLION)
TABLE 73 NORTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY END PRODUCT, 2018-2025 (KT)
TABLE 74 NORTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
TABLE 75 NORTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (KT)
11.2.1 US
11.2.1.1 High concentration of key players in the country and increase in preventive healthcare trends to drive the growth of the market in the coming years
TABLE 76 US: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 77 US: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Manufacturers offer functionality-specific products for consumers that prefer dietary supplements, which widens their growth prospects
TABLE 78 CANADA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 79 CANADA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.2.3 MEXICO
11.2.3.1 Increase in foreign direct investments and rise in consumer awareness regarding healthier lifestyles associated with dietary supplements to drive the market growth for nutraceutical excipients
TABLE 80 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 81 MEXICO: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.3 EUROPE
TABLE 82 EUROPE: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 83 EUROPE: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY COUNTRY, 2018-2025 (KT)
TABLE 84 EUROPE: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 85 EUROPE: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (KT)
TABLE 86 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 87 EUROPE: MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (KT)
TABLE 88 EUROPE: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY END PRODUCT, 2018-2025 (USD MILLION)
TABLE 89 EUROPE: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY END PRODUCT, 2018-2025 (KT)
TABLE 90 EUROPE: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
TABLE 91 EUROPE: MARKET SIZE, BY FORM, 2018-2025 (KT)
11.3.1 GERMANY
11.3.1.1 Increase in innovations in food products to cater to the demands of consumers and key players in the market to drive the market growth in the coming years
TABLE 92 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 93 GERMANY: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.3.2 FRANCE
11.3.2.1 Innovations in product formulations to cater to the increased consumer demands drives the market growth
TABLE 94 FRANCE: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 95 FRANCE: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.3.3 UK
11.3.3.1 Growth of the functional/fortified food & beverage industry in the country to drive the demand for nutraceutical excipients
TABLE 96 UK: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 97 UK: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Rise in the growth of the food and beverage industry and the number of health-conscious consumers to drive the demand for nutraceutical excipients in the country
TABLE 98 ITALY: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 99 ITALY: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Increase in initiatives taken by local and national agencies for consumer affairs regarding the safety and benefits of food products to encourage the consumption of nutraceutical excipients
TABLE 100 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 101 SPAIN: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.3.6 REST OF EUROPE
11.3.6.1 Increase in functionalities of excipients drives the market growth but stringent registration processes continues to hinder it
TABLE 102 REST OF EUROPE: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 103 REST OF EUROPE: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 40 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 104 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 105 ASIA PACIFIC: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY COUNTRY, 2018-2025 (KT)
TABLE 106 ASIA PACIFIC: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 107 ASIA PACIFIC: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (KT)
TABLE 108 ASIA PACIFIC: MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 109 ASIA PACIFIC: MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (KT)
TABLE 110 ASIA PACIFIC: MARKET SIZE, BY END PRODUCT, 2018-2025 (USD MILLION)
TABLE 111 ASIA PACIFIC: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY END PRODUCT, 2018-2025 (KT)
TABLE 112 ASIA PACIFIC: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
TABLE 113 ASIA PACIFIC: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (KT)
11.4.1 CHINA
11.4.1.1 Rise in preference for nutraceutical products and innovations in dietary supplement formulations and fortified food products to drive the demand
TABLE 114 CHINA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 115 CHINA: MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Rise in healthcare costs and higher life expectancy due to preventive healthcare measures to drive the growth of the market
TABLE 116 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 117 JAPAN: MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Rise in awareness about the health benefits provided by dietary supplements and the increase in occurrences of chronic diseases to drive the market growth in the country
TABLE 118 INDIA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 119 INDIA: MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
11.4.4 AUSTRALIA & NEW ZEALAND
11.4.4.1 High spending capacity on nutritional products and an increase in disposable incomes to drive the market growth in the coming years
TABLE 120 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 121 AUSTRALIA & NEW ZEALAND: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.4.5 REST OF ASIA PACIFIC
11.4.5.1 Government initiatives and changing consumer preferences for health-enriching foods to encourage the growth of the market in these countries
TABLE 122 REST OF ASIA PACIFIC: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 123 REST OF ASIA PACIFIC: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.5 SOUTH AMERICA
TABLE 124 SOUTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 125 SOUTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY COUNTRY, 2018-2025 (KT)
TABLE 126 SOUTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 127 SOUTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (KT)
TABLE 128 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 129 SOUTH AMERICA: MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (KT)
TABLE 130 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY END PRODUCT, 2018-2025 (USD MILLION)
TABLE 131 SOUTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY END PRODUCT, 2018-2025 (KT)
TABLE 132 SOUTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
TABLE 133 SOUTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (KT)
11.5.1 BRAZIL
11.5.1.1 Growing awareness regarding the benefits of functional foods, sports nutrition, and dietary supplements benefits for preventive healthcare to drive the demand for nutraceutical excipients
TABLE 134 BRAZIL: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 135 BRAZIL: MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
11.5.2 ARGENTINA
11.5.2.1 Imbalance in nutrition intake leads to several diseases, which, in turn, drives the growth of the market
TABLE 136 ARGENTINA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 137 ARGENTINA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.5.3 REST OF SOUTH AMERICA
11.5.3.1 Government initiatives promoting the adoption of healthier dietary lifestyles to drive the market growth for nutraceutical excipients in the coming years
TABLE 138 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 139 REST OF SOUTH AMERICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
TABLE 140 MIDDLE EAST & AFRICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY REGION, 2018-2025 (USD MILLION)
TABLE 141 MIDDLE EAST & AFRICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY REGION, 2018-2025 (KT)
TABLE 142 MIDDLE EAST & AFRICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 143 MIDDLE EAST & AFRICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (KT)
TABLE 144 MIDDLE EAST AND AFRICA: MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 145 MIDDLE EAST AND AFRICA: MARKET SIZE FOR BINDERS, BY SUBFUNCTIONALITY, 2018-2025 (KT)
TABLE 146 MIDDLE EAST & AFRICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY END PRODUCT, 2018-2025 (USD MILLION)
TABLE 147 MIDDLE EAST & AFRICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY END PRODUCT, 2018-2025 (KT)
TABLE 148 MIDDLE EAST AND AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2025 (USD MILLION)
TABLE 149 MIDDLE EAST AND AFRICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (KT)
11.6.1 MIDDLE EAST
11.6.1.1 Rise in obesity and other health-related concerns to drive the growth of the market
TABLE 150 MIDDLE EAST: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 151 MIDDLE EAST: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
11.6.2 AFRICA
11.6.2.1 Intra-African trade policies and investments in the country by global nutraceutical players to drive the market growth
TABLE 152 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2025 (USD MILLION)
TABLE 153 AFRICA: MARKET SIZE FOR NUTRACEUTICAL EXCIPIENTS, BY FORM, 2018-2025 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 178)
12.1 OVERVIEW
12.2 MARKET EVALUATION FRAMEWORK
FIGURE 41 MARKET EVALUATION FRAMEWORK: 2017 TO 2020
12.3 COMPETITIVE LEADERSHIP MAPPING
12.3.1 STARS
12.3.2 EMERGING LEADER
12.3.3 PERVASIVE
12.3.4 EMERGING COMPANIES
FIGURE 42 NUTRACEUTICAL EXCIPIENTS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2020 (TOP 20)
12.4 START-UP MICROQUADRANT
12.4.1 PROGRESSIVE COMPANIES
12.4.2 RESPONSIVE COMPANIES
12.4.3 DYNAMIC COMPANIES
12.4.4 STARTING BLOCKS
FIGURE 43 NUTRACEUTICAL EXCIPIENTS MARKET (GLOBAL) START-UP COMPETITIVE LEADERSHIP MAPPING, 2020 (TOP 10)
FIGURE 44 KEY DEVELOPMENTS OF LEADING PLAYERS IN THE NUTRACEUTICAL EXCIPIENTS MARKET, 2017-2020
12.5 MARKET SHARE ANALYSIS, 2020
FIGURE 45 CARGILL DOMINATED THE NUTRACEUTICAL EXCIPIENTS MARKET IN 2019
12.6 COMPETITIVE SCENARIO
12.6.1 NEW PRODUCT LAUNCHES
TABLE 154 NEW PRODUCT LAUNCHES
12.6.2 EXPANSIONS & INVESTMENTS
TABLE 155 EXPANSIONS & INVESTMENTS
12.6.3 MERGERS & ACQUISITIONS
TABLE 156 MERGERS & ACQUISITIONS
12.6.4 AGREEMENTS, JOINT VENTURES, AND PARTNERSHIPS
TABLE 157 AGREEMENTS, JOINT VENTURES, AND PARTNERSHIPS
13 COMPANY PROFILES (Page No. - 193)
(Business overview, Products offered, Recent Developments, SWOT Analysis, MNM view)*
13.1 DUPONT
FIGURE 46 DUPONT: COMPANY SNAPSHOT
13.2 KERRY GROUP PLC
FIGURE 47 KERRY GROUP PLC: COMPANY SNAPSHOT
13.3 INGREDION INC
FIGURE 48 INGREDION INC: COMPANY SNAPSHOT
13.4 SENSIENT TECHNOLOGIES CORPORATION
FIGURE 49 SENSIENT TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT
13.5 ASSOCIATED BRITISH FOODS (ABF) PLC
FIGURE 50 ASSOCIATED BRITISH FOOD (ABF) PLC: COMPANY SNAPSHOT
13.6 BASF SE
FIGURE 51 BASF SE: COMPANY SNAPSHOT
13.7 ROQUETTE FRERES
FIGURE 52 ROUQUETTE FRERES: COMPANY SNAPSHOT
13.8 MEGGLE GROUP WASSERBURG
13.9 CARGILL INCORPORATED
FIGURE 53 CARGILL INCORPORATED: COMPANY SNAPSHOT
13.10 ASHLAND GLOBAL HOLDINGS INC
FIGURE 54 ASHLAND GLOBAL HOLDINGS INC: COMPANY SNAPSHOT
*Details on Business overview, Products offered, Recent Developments, SWOT Analysis, MNM view might not be captured in case of unlisted companies.
14 COMPANY PROFILES (START-UPS) (Page No. - 226)
14.1 HILMAR INGREDIENTS
14.2 IMCD
FIGURE 55 IMCD: COMPANY SNAPSHOT
14.3 INNOPHOS HOLDINGS INC
FIGURE 56 INNOPHOS HOLDINGS INC: COMPANY SNAPSHOT
14.4 JRS PHARMA
14.5 BIOGRUND GMBH
14.6 PHARMA LINE INT'L CORP
14.7 AZELIS CHEMICAL LTD
14.8 DAICEL GROUP
FIGURE 57 DAICEL GROUP: COMPANY SNAPSHOT
14.9 JIGS CHEMICAL LTD
14.1 PANCHAMRUT CHEMICALS
15 LIST OF COMPANIES IN NUTRACEUTICAL MARKET ECOSYSTEM (Page No. - 250)
15.1 NUTRACEUTICAL INGREDIENT MANUFACTURERS
15.2 NUTRACEUTICAL FOOD & BEVERAGE MANUFACTURERS
15.3 DIETARY SUPPLEMENTS MANUFACTURERS
16 APPENDIX (Page No. - 251)
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
16.3 AVAILABLE CUSTOMIZATIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
The study involved four major activities for estimating the global market size of nutraceutical excipients. Exhaustive secondary research was conducted to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of the segments and sub-segments.
Secondary Research
In the secondary research process, various sources such as the Food and Agriculture Organization (FAO), United States Department of Agriculture (USDA), European Food Safety Authority (EFSA), World Health Organization (WHO), All India Food Processing Association (AIFPA), Environmental Protection Agency (EPA), the Food Safety Council (FSC), National Center for Biotechnology Information (NCBI), National Library of Medicine (NLM), National Institutes of Health (NIH), Center for Food Safety (CFS), World Bank, and Organization for Economic Co-operation and Development (OECD), were referred to, to identify and collect information for this study. The secondary sources also include clinical studies & journals, press releases, investor presentations of companies, white papers, certified publications, articles by recognized authors and regulatory bodies, trade directories, and paid databases.
Secondary research was mainly conducted to obtain key information about the industry’s supply chain, the total pool of key players, market classification & segmentation according to the industry trends to the bottom-most level, and geographical markets. It was also used to obtain information about the key developments from a market-oriented perspective.
Primary Research
The market comprises several stakeholders in the supply chain, which include raw material suppliers and nutraceutical excipient manufacturers. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The primary interviewees from the supply-side include exogenous nutraceutical excipient manufacturers. The primary sources from the demand-side include distributors, wholesalers, importers, and exporters of nutraceutical excipients.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the total size of the nutraceutical excipients market. These approaches were also used extensively to estimate the size of various sub-segments in the market for the base year (2019) in terms of value. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets were identified through extensive secondary research.
- All possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
- All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
- The industry’s value chain and market size, in terms of value, were determined through primary and secondary research.
- The research included the study of reports, reviews, and newsletters of top market players, along with the extensive interviews for opinions from leaders such as CEOs, directors, and marketing executives.
Data Triangulation
After arriving at the overall market size from the estimation process explained above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides. In addition, the market size was validated using both the top-down and bottom-up approaches, which was then verified through primary interviews. Thus, there are three approaches; first is the top-down approach, second is the bottom-up approach, and the third approach includes learning and verification of collected information through expert interviews. Only when the values derived through these three approaches match is the data assumed to be correct.
Report Objectives
MARKET INTELLIGENCE
- Determining and projecting the size of the nutraceutical excipients market, with respect to functionality, form, end product, and regional markets, over five years, ranging from 2020 to 2025
- Identifying the attractive opportunities in the market by determining the largest and fastest-growing segments across regions
- Providing detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- Analyzing the micromarkets, with respect to individual growth trends, prospects, and their contribution to the total market
COMPETITIVE INTELLIGENCE
- Identifying and profiling the key market players in the nutraceutical excipients market
- Providing a comparative analysis of market leaders based on the following:
- Product offerings
- Business strategies
- Strengths and weaknesses
- Key financials
- Understanding the competitive landscape and identifying the major growth strategies adopted by players across the key regions
- Analyzing the value chain and products across the key regions and their impact on the prominent market players
- Providing insights into key product innovations and investments in the nutraceutical excipients market
Available Customizations:
With the given market data, MarketsandMarkets offers customizations according to client-specific needs. The following customization options are available for the report:
GEOGRAPHIC ANALYSIS
- Further breakdown of the Rest of Asia Pacific nutraceutical excipients market into South Korea and Southeast Asian countries such as Indonesia, Vietnam, the Philippines, Malaysia, Singapore, and Thailand.
- Further breakdown of the Rest of Europe nutraceutical excipients market into Russia, Poland, Switzerland, the Netherlands, and other EU and non-EU countries.
- Further breakdown of the Rest of South America nutraceutical excipients market into Chile, Colombia, Peru, Venezuela, Ecuador, Guatemala, and the Dominican Republic.
SEGMENTAL ANALYSIS
- Further breakdown of the binder segment in the nutraceutical excipients market into cellulose, povidone, starch, and other binders.
- Further breakdown of the other functionalities in the nutraceutical excipients market into preservatives, colorants, and antioxidants.
- Further breakdown of the other end products in the nutraceutical excipients market fibers, carbohydrates, and plant extracts.
COMPANY INFORMATION
- Detailed analysis and profiling of additional market players (up to five)
Growth opportunities and latent adjacency in Nutraceutical Excipients Market